ADVFN US – Market Content Editor
-
U.S. Worker Productivity Rebounds in Q2, Jobless Claims Rise Unexpectedly
The productivity of American workers bounced back in the second quarter of 2025, showing strong gains after a sluggish start to the year, according to preliminary figures published by the U.S. Labor Department on Thursday. Productivity, which measures output per hour worked, increased by 2.4% between April and June. This marks a sharp turnaround from…
-
Dow Jones, S&P, Nasdaq, Futures, Wall Street Rally Set to Extend as Apple Boosts Investment and Trump Targets Chip Imports
U.S. stock futures pointed higher on Thursday morning, signaling a continuation of Wednesday’s strong rally, as investor sentiment was lifted by major corporate developments and a new push for domestic manufacturing. Markets are responding positively to comments from former President Donald Trump, who announced a sweeping 100% tariff on imported semiconductors and chips. The move…
-
Eli Lilly Shares Drop Over 12% Premarket as Weight-Loss Pill Study Disappoints Despite Strong Earnings
Eli Lilly (NYSE:LLY) shares fell more than 12% in premarket U.S. trading on Thursday following a study showing its experimental weight-loss pill achieved less body weight reduction compared to a competitor from Novo Nordisk (NYSE:NVO). The late-stage trial revealed that Lilly’s oral GLP-1 drug, orforglipron, helped patients lose an average of 12.4% of their body…
-
Penn Entertainment Beats Q2 Expectations as Strong Retail Results Boost Stock
Penn Entertainment, Inc. (NASDAQ:PENN) reported second-quarter results on Thursday that surpassed analyst forecasts, with both adjusted earnings and revenue beating estimates. Shares rose 1.88% in pre-market trading following the earnings announcement. The casino and entertainment company posted adjusted earnings per share of $0.10, well above the consensus estimate of -$0.02. Revenue came in at $1.77…
-
Novo Nordisk Shares Surge After Eli Lilly’s Obesity Pill Falls Short
Novo Nordisk (NYSE:NVO) shares jumped over 11% in premarket trading on Thursday following disappointing data on Eli Lilly’s oral obesity drug orforglipron, which raised concerns over its efficacy and tolerability. Wolfe Research described the 11.5% placebo-adjusted weight loss at 72 weeks as “modestly below investor expectations of 13–15%.” While analysts acknowledged the study cleared a…
-
GlobalFoundries Stock Surges After Expanding Partnership with Apple
Shares of GlobalFoundries (NASDAQ:GFS) rose 7% following the announcement of an expanded partnership with Apple (NASDAQ:AAPL) aimed at advancing wireless connectivity and power management technologies, strengthening U.S. leadership in semiconductor manufacturing. The enhanced collaboration will allow GlobalFoundries to accelerate investments at its semiconductor fabrication plant in Malta, New York. The partnership focuses on producing critical…
-
D-Wave Quantum Shares Drop Nearly 3% as Earnings Miss Overshadows Revenue Growth
On Thursday, D-Wave Quantum Inc. (NYSE:QBTS) reported second-quarter results that fell short of analyst earnings expectations despite posting revenue gains. Shares fell 2.79% in pre-market trading following the announcement. The quantum computing firm posted an adjusted loss of $0.08 per share, missing the analyst estimate of a $0.05 per share profit. Revenue, however, rose to…
-
Dentsply Sirona Surpasses Q2 Earnings Expectations Despite Revenue Decline
Dentsply Sirona (NASDAQ:XRAY) reported second-quarter earnings on Thursday that beat analyst forecasts, delivering adjusted earnings per share of $0.52, above the consensus estimate of $0.50. The dental equipment maker posted revenue of $936 million, slightly exceeding the projected $933.63 million, even as total sales declined compared to the same period last year. Shares rose 0.88%…
-
Playtika Falls Short of Q2 Estimates as Revenue Disappoints, Shares Decline
Playtika Holding Corp. (NASDAQ:PLTK) reported second-quarter results on Thursday that missed analyst expectations, causing shares to drop 3.9% as the mobile gaming company faced challenges with weakening performance in key titles. The company recorded adjusted earnings of $0.09 per share, well below the consensus estimate of $0.19. Revenue reached $696 million, slightly under the $705.4…
-
Spectrum Brands Misses Q3 Estimates Amid Tariff Headwinds
Spectrum Brands Holdings, Inc. (NYSE:SPB) reported third-quarter fiscal 2025 results on Thursday that fell short of analyst expectations, as the company faced tariff-related disruptions and weakening consumer demand. Adjusted earnings per share came in at $1.24, below the analyst forecast of $1.35, while revenue declined 10.2% year-over-year to $699.6 million, missing the consensus estimate of…